Analyst Recommendations

KeyBanc analyst issues OVERWEIGHT recommendation for XHR on April 5, 2024 07:06AM ET. The previous analyst recommendation was Overweight.XHR was trading at $14.97 at issue of the analyst...

April 5, 2024   XHR -1.85%

Susquehanna analyst issues NEUTRAL recommendation for SPWR on April 5, 2024 06:59AM ET. The previous analyst recommendation was Neutral.SPWR was trading at $2.85 at issue of the analyst...

April 5, 2024   SPWR -0.30%

Oppenheimer analyst issues OUTPERFORM recommendation for ANGO on April 5, 2024 07:02AM ET. ANGO was trading at $6.4 at issue of the analyst recommendation.The overall analyst consensus :...

April 5, 2024   ANGO -9.45%

HSBC analyst issues HOLD recommendation for DLO on April 5, 2024 07:03AM ET. The previous analyst recommendation was Hold.DLO was trading at $16.24 at issue of the analyst...

April 5, 2024   DLO -0.21%

Piper Sandler analyst issues NEUTRAL recommendation for TRUP on April 5, 2024 07:19AM ET. The previous analyst recommendation was Neutral.TRUP was trading at $25.51 at issue of the...

April 5, 2024   TRUP -2.10%

Citigroup analyst issues BUY recommendation for EXP on April 5, 2024 05:46AM ET. The previous analyst recommendation was Buy.EXP was trading at $260 at issue of the analyst...

April 5, 2024   EXP -3.24%

Citigroup analyst issues BUY recommendation for LEN on April 5, 2024 05:46AM ET. The previous analyst recommendation was Buy.LEN was trading at $163.64 at issue of the analyst...

April 5, 2024   LEN -4.21%

Hovde Group analyst issues MARKET PERFORM recommendation for FMAO on April 5, 2024 05:45AM ET. FMAO was trading at $21.35 at issue of the analyst recommendation.The overall analyst...

April 5, 2024   FMAO -2.69%

Citigroup analyst issues NEUTRAL recommendation for AZEK on April 5, 2024 05:45AM ET. The previous analyst recommendation was Neutral.AZEK was trading at $49.1 at issue of the analyst...

April 5, 2024   AZEK -0.93%

Citigroup analyst issues BUY recommendation for CRH on April 5, 2024 05:45AM ET. The previous analyst recommendation was Buy.CRH was trading at $84.47 at issue of the analyst...

April 5, 2024   CRH -0.46%